We report factors associated with severe manifestations of histoplasmosis (
such as shock, respiratory failure, and death) in patients with AIDS during
an outbreak. Severe disease was present in 28 of 155 patients (17.9%). The
following factors were associated with severe disease: black race (odds ra
tio [OR], 2.8; 95% confidence interval [CT], 1.2-6.2); hemoglobin lever <9.
5 g/dL (OR, 2.7; 95% CI, 1.2-6.4), partial thromboplastin time >45 s (OR, 3
.1; 95% CI, 1.1-9.3); alkaline phosphatase level >2.5 times normal (OR, 3.4
; 95% CI, 1.3-8.7); aspartate aminotransferase level >2.5 times normal (OR,
4.2; 95% CI, 1.7-10.0); bilirubin level concentration >1.5 mg/dL (OR, 9.2;
95% CI, 2.5-34.3); creatinine concentration >2.1 mg/dL (OR, 8.3; 95% CI, 2
.2-31.9); and albumin concentration <3.5 g/dL (OR, 4.6; 95% CI, 1.3-16.4).
Zidovudine use was associated with decreased risk of severe disease (OR, 0.
3; 95% CI, 0.1-0.7). Multivariate analysis showed that a creatinine value >
2.1 mg/dL (OR, 9.5; 95% CI, 1.7-52) and an albumin value <3.5 g/dL (OR, 4.8
; 95% CI, 1.0-22) were associated with an increased risk of severe disease,
and zidovudine therapy remained associated with a decreased risk (OR, 0.2;
95% CI, 0.1-0.6). Findings associated with severe histoplasmosis should be
recognized early and the cases managed aggressively.